Latest Financial Disclosure News

Ex-CEO Geoff Cockerill has initiated court proceedings against Vitura Limited, alleging breaches of the Fair Work Act related to his January 2026 departure. Vitura maintains all contractual obligations were met and plans to resolve the dispute swiftly.

Plenti Group Limited (ASX:PLT) has smashed its $3 billion loan portfolio target two months ahead of schedule, delivering a 117% surge in cash profit before tax to $30.8 million for FY26. The fintech lender’s growth was fuelled by record loan originations, robust credit performance, and strategic technology investments.

Yowie Group has increased its secured working capital loan facility with Keybridge Capital from A$2.5 million to A$3.5 million, maintaining the maturity date at 31 August 2026. This latest amendment reflects ongoing efforts to shore up liquidity amid operational challenges.

Dataworks has officially launched BetGuard, iGaming Ontario's Centralised Self-Exclusion tool, alongside a dedicated Contact Centre, marking its expansion into a second regulated jurisdiction for responsible gambling technology.

ALS Limited reported a 25.8% jump in underlying net profit after tax to AUD 381.2 million for FY26, driven by strong commodity testing demand and margin expansion. The company raised its dividend and advanced major hub lab projects while navigating a post-year-end cyber incident.

Synlait Milk has obtained waivers from its syndicated banks on key financial covenants for the quarter ending April 2026, reflecting ongoing operational and market challenges.

Viva Energy is progressing repairs at its Geelong Refinery following a fire that disrupted key units, aiming to resume near-full production by June while maintaining fuel supply.

Recce Pharmaceuticals bolsters its clinical and commercial pipeline with a $5.3 million AUD R&D tax rebate, a second U.S. Army research agreement for its RECCE 327 Gel, and a key patent granted in Brazil, while progressing Phase 3 trials in Indonesia.

HighCom Technology secures a nearly A$10 million contract from the Australian Defence for counter small uncrewed aerial systems, marking its first major C-UAS order and reinforcing its defence sector presence.

Biome Australia’s Activated Probiotics brand surpasses one million boxes sold in Australia, approaches top pharmacy ranking, and launches nationally in Canada, setting the stage for FY26 profitability.

Firebird Metals has locked in exclusive global rights to key LMFP patents through 2045 and commissioned lithium-manganese-rich cathode equipment, progressing its Australian Demonstration Plant with a $2 million ARENA grant.

Island Pharmaceuticals has cleared a major regulatory hurdle with the US FDA, confirming a clinical development path for its antiviral Galidesivir under the Animal Rule. Backed by a $9 million capital raise and strategic partnerships, the company is poised for potential US government procurement and biodefence market entry.